Number of Repetitions in Re-Randomization Tests

被引:0
|
作者
Zhang, Yilong [1 ]
Zhao, Yujie [2 ]
Wang, Bingjun [2 ]
Luo, Yiwen [2 ]
机构
[1] Meta Platforms Inc, Real Labs, Menlo Pk, CA USA
[2] Merck & Co Inc, Biostat & Res Decis Sci, Rahway, NJ 07065 USA
关键词
clinical trial; group sequential design; hypothesis test; interim analysis; numerical error; re-randomization test;
D O I
10.1002/pst.2438
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
In covariate-adaptive or response-adaptive randomization, the treatment assignment and outcome can be correlated. Under this situation, the re-randomization test is a straightforward and attractive method to provide valid statistical inferences. In this paper, we investigate the number of repetitions in tests. This is motivated by a group sequential design in clinical trials, where the nominal significance bound can be very small at an interim analysis. Accordingly, re-randomization tests lead to a very large number of required repetitions, which may be computationally intractable. To reduce the number of repetitions, we propose an adaptive procedure and compare it with multiple approaches under predefined criteria. Monte Carlo simulations are conducted to show the performance of different approaches in a limited sample size. We also suggest strategies to reduce total computation time and provide practical guidance in preparing, executing, and reporting before and after data are unblinded at an interim analysis, so one can complete the computation within a reasonable time frame.
引用
收藏
页数:15
相关论文
共 50 条
  • [1] Re-randomization tests in clinical trials
    Proschan, Michael A.
    Dodd, Lori E.
    STATISTICS IN MEDICINE, 2019, 38 (12) : 2292 - 2302
  • [2] Weighted re-randomization tests for minimization with unbalanced allocation
    Han, Baoguang
    Yu, Menggang
    McEntegart, Damian
    PHARMACEUTICAL STATISTICS, 2013, 12 (04) : 243 - 253
  • [3] Re-randomization tests for unplanned changes in clinical trials
    Proschan, Michael A.
    CLINICAL TRIALS, 2017, 14 (05) : 425 - 431
  • [4] TOOLS FOR RE-RANDOMIZATION
    Lara, Bernardo
    BULLETIN OF ECONOMIC RESEARCH, 2019, 71 (03) : 517 - 532
  • [5] Shift in re-randomization distribution with conditional randomization test
    Kuznetsova, Olga M.
    Tymofyeyev, Yevgen
    PHARMACEUTICAL STATISTICS, 2013, 12 (02) : 82 - 91
  • [6] Encryption and Re-Randomization Techniques for Malware Propagation
    Abbasi, Ahsan Rasheed
    Afzal, Mehreen
    Iqbal, Waseem
    Mussiraliyeva, Shynar
    Khan, Fawad
    Rehman, Awais Ur
    IEEE ACCESS, 2021, 9 (09): : 132522 - 132532
  • [7] The Effect of Re-randomization in a Smoking Cessation Trial
    Park, Eunhee
    Choi, Seung Hee
    Duffy, Sonia A.
    AMERICAN JOURNAL OF HEALTH BEHAVIOR, 2016, 40 (05): : 667 - 674
  • [8] MARDU: Efficient and Scalable Code Re-randomization
    Jelesnianski, Christopher
    Yom, Jinwoo
    Min, Changwoo
    Jang, Yeongjin
    PROCEEDINGS OF THE 13TH ACM INTERNATIONAL SYSTEMS AND STORAGE CONFERENCE (SYSTOR 2020), 2020, : 49 - 60
  • [9] Re-randomization tests as sensitivity analyses to confirm immunological noninferiority of an investigational vaccine: Case study
    Grassano, Luca
    Ranzato, Giulia
    Pellegrini, Michele
    Costantini, Marco
    PHARMACEUTICAL STATISTICS, 2023, 22 (03) : 570 - 576
  • [10] Shuffler: Fast and Deployable Continuous Code Re-Randomization
    Williams-King, David
    Gobieski, Graham
    Williams-King, Kent
    Blake, James P.
    Yuan, Xinhao
    Colp, Patrick
    Zheng, Michelle
    Kemerlis, Vasileios P.
    Yang, Junfeng
    Aiello, William
    PROCEEDINGS OF OSDI'16: 12TH USENIX SYMPOSIUM ON OPERATING SYSTEMS DESIGN AND IMPLEMENTATION, 2016, : 367 - 382